Literature DB >> 16317028

Amelioration of oxidant stress by the defensin lysozyme.

Huixian Liu1, Feng Zheng, Qi Cao, Bin Ren, Li Zhu, Gary Striker, Helen Vlassara.   

Abstract

Reactive oxidant species (ROS), products of normal metabolism, cause oxidant injury if they accumulate in pathological amounts. Lysozyme (LZ) contains an 18-amino acid domain that binds agents such as advanced glycation end products (AGE) that generate ROS. We examined whether endogenous LZ affected physiological, or baseline, antioxidant balance and provided protection against both acute and chronic oxidant injury, using paraquat and H2O2 as agents of acute injury and AGE for chronic injury. Hen egg LZ-Tg mice had threefold higher serum LZ levels and decreased baseline AGE levels in serum and liver. These findings were linked to an enhanced baseline systemic GSH-to-GSSG ratio. Baseline levels of stress response genes p66(Shc) and c-Jun were also lower in liver tissue of LZ-Tg mice. Survival from severe oxidant injury induced by paraquat was twofold greater in LZ-Tg mice. In addition, LZ-Tg mice were resistant to chronic exogenous oxidant stress (OS) induced by AGE administration. Preincubation of hepatocytes (Hep G2) with LZ suppressed redox balance at baseline, as well as OS after added paraquat, AGE, or H2O2. LZ also ameliorated paraquat-enhanced cell apoptosis in a dose-dependent manner and suppressed AGE-induced p66(Shc) expression and c-Jun phosphorylation in Hep G2 cells. Thus LZ provides protection against acute and chronic oxidant injury by mechanisms involving suppression of ROS generation and of OS response genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317028     DOI: 10.1152/ajpendo.00349.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  21 in total

1.  Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.

Authors:  Weijing Cai; John Cijiang He; Li Zhu; Xue Chen; Sylvan Wallenstein; Gary E Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

2.  Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme.

Authors:  Huixian Liu; Feng Zheng; Zhu Li; Jaime Uribarri; Bin Ren; Randolph Hutter; James R Tunstead; Juan Badimon; Gary E Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Is variation in total antioxidant capacity of human milk associated with levels of bio-active proteins?

Authors:  R Mehta; A Petrova
Journal:  J Perinatol       Date:  2013-12-05       Impact factor: 2.521

4.  Lysozyme Gene Expression in 3T3-L1 Cells Sustains Expression of Adipogenic Genes and Adipocyte Differentiation.

Authors:  Aina Lluch; Jessica Latorre; José Manuel Fernández-Real; José María Moreno-Navarrete
Journal:  Front Cell Dev Biol       Date:  2022-06-15

5.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

6.  Development, characterization, and technical applications of a fish lysozyme-specific monoclonal antibody (mAb M24-2).

Authors:  Marlee B Marsh; Charles D Rice
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2009-11-08       Impact factor: 2.268

Review 7.  Glycotoxins in the diet promote diabetes and diabetic complications.

Authors:  Helen Vlassara; Gary Striker
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

Review 8.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

Review 9.  Role of advanced glycation end products in cellular signaling.

Authors:  Christiane Ott; Kathleen Jacobs; Elisa Haucke; Anne Navarrete Santos; Tilman Grune; Andreas Simm
Journal:  Redox Biol       Date:  2014-01-09       Impact factor: 11.799

10.  Vitamin B6 reduces hippocampal apoptosis in experimental pneumococcal meningitis.

Authors:  Denise C Zysset-Burri; Caroline L Bellac; Stephen L Leib; Matthias Wittwer
Journal:  BMC Infect Dis       Date:  2013-08-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.